4 free views remaining today
retinitis pigmentosa 59
ICD-10 Codes
Related ICD-10:
Description
Retinitis Pigmentosa (RP) Description
Retinitis pigmentosa (RP) is a group of genetic disorders that affect the retina's ability to respond to light, causing a slow loss of vision [1]. It is a group of inherited eye diseases that cause visual problems, including irregular retina pigmentation [3].
The condition often leads to progressive loss of night and peripheral vision, which can eventually lead to legal and sometimes complete blindness [8]. An early symptom of RP is trouble with night vision, making it difficult for individuals to see in low-light environments [6].
RP is a clinically and genetically heterogeneous group of inherited retinal disorders characterized by diffuse pigmentary changes in the retina [7]. The condition affects the retina, which is the light-sensitive tissue at the back of the eye, causing progressive deterioration of the retina [9].
Key Features:
- Slow loss of vision
- Irregular retina pigmentation
- Trouble with night vision
- Progressive loss of peripheral vision
- Can lead to legal and sometimes complete blindness
Note: The information provided is based on the search results and may not be an exhaustive list of symptoms or characteristics. If you have specific questions or concerns, please feel free to ask!
Additional Characteristics
- slow loss of vision
- irregular retina pigmentation
- trouble with night vision
- progressive loss of peripheral vision
- can lead to legal and sometimes complete blindness
Signs and Symptoms
Common Signs and Symptoms of Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of rare eye diseases that affect the retina, leading to progressive vision loss. The signs and symptoms of RP can vary from person to person, but here are some common ones:
- Night blindness: This is often the first sign of RP, where individuals have difficulty seeing in dimly lit environments or at dusk.
- Tunnel vision: As the disease progresses, people with RP may experience tunnel vision, where they can only see objects directly in front of them.
- Sensitivity to light: Some people with RP may be uncomfortable in bright light or experience photophobia (sensitivity to light).
- Loss of central vision: In advanced stages of RP, individuals may lose their ability to see colors and have very low vision.
- Peripheral ring scotoma: This is a type of visual field defect that can be detected by visual field testing.
These symptoms usually start in childhood or adolescence and progress gradually over time. It's essential for people with RP to seek medical attention early on to manage their condition effectively.
References:
- [1] Symptoms usually start in childhood, and most people eventually lose most of their sight. There’s no cure for RP. But vision aids and rehabilitation (training) programs can help people with RP make the most of their vision. ([2])
- [3] Retinitis pigmentosa causes a slow decline in eyesight and the field of vision. Symptoms usually begin in childhood or adolescence. ([4])
- [5] Loss of night vision is when you cannot see anything in the
Additional Symptoms
- Night blindness
- Tunnel vision
- Peripheral ring scotoma
- loss of vision
- light sensitivity
Diagnostic Tests
Diagnostic Tests for Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of inherited eye diseases that affect the retina, and diagnostic tests play a crucial role in its diagnosis. Here are some common diagnostic tests used to investigate RP:
- Electro-diagnostic tests: These tests include electroretinogram (ERG), electro-oculogram (EOG), and multifocal electroretinogram (mfERG). They provide an objective measure of rod and cone function across the retina [3].
- Genetic testing: This test looks at a sample of your blood or other tissues to see if you have certain genes that are associated with RP. Genetic testing can identify specific genetic mutations that cause RP, such as the RPE65 gene mutation [4].
- Electroretinogram (ERG): ERG is the most critical diagnostic test for RP because it provides an objective measure of rod and cone function across the retina [3]. It helps confirm the diagnosis by demonstrating attenuated rod and cone signals [8].
- Optical Coherence Tomography (OCT) scan: An OCT scan can show loss of photoreceptors, which is a characteristic feature of RP. This test can also detect pigment deposits in the fundus [6].
Other Diagnostic Tests
In addition to these tests, other diagnostic tools may be used to investigate RP. These include:
- 159 gene panel: This panel includes assessment of non-coding variants and the maternally inherited mitochondrial genome [7].
- Peripheral visual field loss: A diagnosis of RP is often based on peripheral visual field loss, which can be detected through a comprehensive eye examination.
References
[1] Context 2 [3] Context 3 [4] Context 5 [6] Context 6 [7] Context 7 [8] Context 8
Additional Diagnostic Tests
- Genetic testing
- Electroretinogram (ERG)
- Electro-diagnostic tests
- Optical Coherence Tomography (OCT) scan
- 159 gene panel
- Peripheral visual field loss
Treatment
Current Treatments for Retinitis Pigmentosa
While there is no cure for retinitis pigmentosa (RP), several treatments are available to manage the symptoms and slow down disease progression. Here are some of the current drug treatments:
- Luxturna (Voretigene Neparvovec): This is a gene therapy approved by the FDA that targets the RPE65 gene, which is responsible for RP in some individuals. It has shown promising results in improving vision in people with inherited retinal diseases [1].
- Oral Acetazolamide: Studies have shown that oral acetazolamide can improve visual function in some patients with RP [2]. However, more research is needed to confirm its effectiveness.
- N-acetylcysteine (NAC): A Phase 3 clinical trial of NAC for the treatment of RP has been launched by Johns Hopkins University [3].
- Gene Therapy: New research suggests that a new kind of gene therapy can improve vision in people who have lost nearly all sight to retinitis pigmentosa [4].
Other Potential Treatments
Researchers are also exploring other potential treatments, including:
- Nanobodies: A nanobody has been discovered by UC Irvine researchers that may lead to treatment for RP [5].
- QR-421a: This therapy is injected into the retina and allows cells to produce a healthier version of the USH2A protein [6].
Important Note
It's essential to note that these treatments are not available for everyone with RP, and more research is needed to confirm their effectiveness. If you or someone you know has been diagnosed with RP, consult with a healthcare professional to discuss the best treatment options.
References:
[1] Context 1: by N Cross · 2022 · Cited by 37 [2] Context 5: May 16, 2024 [3] Context 7: Oct 7, 2024 [4] Context 9: Oct 20, 2024 [5] Context 8: Aug 29, 2023 [6] Context 3: Aug 16, 2021
Recommended Medications
- Gene Therapy
- N-acetylcysteine (NAC)
- Luxturna (Voretigene Neparvovec)
- QR-421a
- Oral Acetazolamide
- Nanobodies
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis for retinitis pigmentosa (RP) involves considering other conditions that may present with similar symptoms. According to the available information, the following are some of the conditions that should be considered in the differential diagnosis of RP:
- Traumatic retinopathy: This condition can cause damage to the retina due to trauma or injury, leading to symptoms such as vision loss and blind spots [7].
- Retinal inflammatory diseases: These include conditions such as birdshot choroidoretinopathy, serpiginous retinopathy, multifocal placoid pigment epitheliopathy, and sarcoidosis, which can cause inflammation in the retina and lead to symptoms similar to RP [4].
- Autoimmune paraneoplastic retinopathy: This is a rare condition where an autoimmune response causes damage to the retina, often associated with cancer [7].
- Drug-induced retinal toxicity: Certain medications can cause damage to the retina, leading to symptoms such as vision loss and blind spots [7].
It's worth noting that the differential diagnosis for RP can be further refined by age of onset. While most individuals are diagnosed in early adulthood, some cases may present earlier or later in life [8]. A comprehensive evaluation by an eye care professional is necessary to determine the correct diagnosis.
References: [4] C Hamel · 2006 · Cited by 1255 [7] Aug 29, 2024 [8] Feb 10, 2022
Additional Differential Diagnoses
- Traumatic retinopathy
- Retinal inflammatory diseases
- Autoimmune paraneoplastic retinopathy
- Drug-induced retinal toxicity
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasDbXref
- MIM:613861
- oboInOwl#id
- DOID:0110352
- core#notation
- DOID:0110352
- IAO_0000115
- A retinitis pigmentosa that has_material_basis_in mutation in the DHDDS gene on chromosome 1p36.11.
- rdf-schema#label
- retinitis pigmentosa 59
- oboInOwl#hasExactSynonym
- RP59
- rdf-schema#subClassOf
- t366202
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- relatedICD
- http://example.org/icd10/H35.5
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4706
- owl#annotatedSource
- t366229
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.